27 November 2017

Touchstone Innovations plc

Issue of equity

Touchstone Innovations plc (AIM: IVO, 'Touchstone' or 'the Company') has allotted 228,676 new ordinary shares of 3 / (three and one thirty-third) pence each in the capital of the Company ('Ordinary Shares') to certain employees of Touchstone, including its four persons discharging managerial responsibilities ('PDMRs'), who exercised options to subscribe for Ordinary Shares at price of 3 /(three and one thirty-third)pence per Ordinary Share.

Application will now be made for such Ordinary Shares to be admitted to trading on AIM ('Admission'), which is expected to occur at 8.00am on 1 December 2017. The new Ordinary Shares, when issued, will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

Following Admission, the Company's total issued and voting share capital will comprise 161,432,800 Ordinary Shares (with no Ordinary Shares being held in treasury). This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information contact:

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

William Rayner, General Counsel and Company Secretary

Jon Davies, Director of Communications

Instinctif Partners

020 7457 2020

Adrian Duffield/Mel Toyne-Sewell/Chantal Woolcock

J.P. Morgan Cazenove (Nominated adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

RBC Capital Markets (Joint corporate broker)

020 7653 4000

Marcus Jackson

Touchstone Innovations plc published this content on 27 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 November 2017 07:06:14 UTC.

Original documenthttps://otp.tools.investis.com/clients/uk/imperial_innovations/rns1/regulatory-story.aspx?cid=859&newsid=952966

Public permalinkhttp://www.publicnow.com/view/4FE548F7573D9250EB9A2109B65141FADFEC164E